Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in OCULAR THERAPEUTIX INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 307,747 shares of OCUL (OCULAR THERAPEUTIX INC), worth $3.7M as of 2025-Q4. The position was increased (++52.9% shares). OCUL represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.7M
Current Shares
307,747
Total Value Change
+$2.5M
Total Shares Change
+121,687
Other major holders of OCUL: BNP PARIBAS FINANCIAL MARKETS, FMR LLC
Increased |
| 307,747 |
+52.9% |
| $3.7M |
| 0.0% |
| $12.20 |
37 |
| 2025-Q3 | Decreased | 201,259 | -36.4% | $2.4M | 0.0% | $12.53 | 0 |
| 2025-Q2 | Increased | 316,276 | +48.5% | $2.9M | 0.0% | $9.22 | 36 |
| 2025-Q1 | Decreased | 212,952 | -2.6% | $1.6M | 0.0% | $7.58 | 0 |
| 2024-Q4 | Increased | 218,588 | +48.0% | $1.9M | 0.0% | $8.35 | 35 |
| 2024-Q3 | Decreased | 147,684 | -20.6% | $1.3M | 0.0% | $8.68 | 0 |
| 2024-Q2 | New | 186,060 | - | $1.3M | 0.0% | $6.84 | 35 |